256 related articles for article (PubMed ID: 22345480)
1. An alternative Kaposi's sarcoma-associated herpesvirus replication program triggered by host cell apoptosis.
Prasad A; Lu M; Lukac DM; Zeichner SL
J Virol; 2012 Apr; 86(8):4404-19. PubMed ID: 22345480
[TBL] [Abstract][Full Text] [Related]
2. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
Wakeman BS; Izumiya Y; Speck SH
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
[TBL] [Abstract][Full Text] [Related]
3. ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle.
Wood JJ; Boyne JR; Paulus C; Jackson BR; Nevels MM; Whitehouse A; Hughes DJ
J Virol; 2016 Oct; 90(20):9543-55. PubMed ID: 27512077
[TBL] [Abstract][Full Text] [Related]
4. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway.
Wang SE; Wu FY; Chen H; Shamay M; Zheng Q; Hayward GS
J Virol; 2004 Apr; 78(8):4248-67. PubMed ID: 15047839
[TBL] [Abstract][Full Text] [Related]
5. Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.
Papp B; Motlagh N; Smindak RJ; Jin Jang S; Sharma A; Alonso JD; Toth Z
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541837
[TBL] [Abstract][Full Text] [Related]
6. X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency.
Wilson SJ; Tsao EH; Webb BL; Ye H; Dalton-Griffin L; Tsantoulas C; Gale CV; Du MQ; Whitehouse A; Kellam P
J Virol; 2007 Dec; 81(24):13578-86. PubMed ID: 17928342
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line.
Gradoville L; Gerlach J; Grogan E; Shedd D; Nikiforow S; Metroka C; Miller G
J Virol; 2000 Jul; 74(13):6207-12. PubMed ID: 10846108
[TBL] [Abstract][Full Text] [Related]
8. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
9. Sirtuin 6 Attenuates Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Suppressing Ori-Lyt Activity and Expression of RTA.
Hu M; Armstrong N; Seto E; Li W; Zhu F; Wang PC; Tang Q
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651359
[TBL] [Abstract][Full Text] [Related]
10. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
Wang SE; Wu FY; Yu Y; Hayward GS
J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
[TBL] [Abstract][Full Text] [Related]
11. Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus.
Chiou CJ; Poole LJ; Kim PS; Ciufo DM; Cannon JS; ap Rhys CM; Alcendor DJ; Zong JC; Ambinder RF; Hayward GS
J Virol; 2002 Apr; 76(7):3421-39. PubMed ID: 11884567
[TBL] [Abstract][Full Text] [Related]
12. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
Lan K; Kuppers DA; Verma SC; Sharma N; Murakami M; Robertson ES
J Virol; 2005 Jun; 79(12):7453-65. PubMed ID: 15919901
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
Lan K; Kuppers DA; Verma SC; Robertson ES
J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma-associated herpesvirus K-bZIP protein is necessary for lytic viral gene expression, DNA replication, and virion production in primary effusion lymphoma cell lines.
Lefort S; Flamand L
J Virol; 2009 Jun; 83(11):5869-80. PubMed ID: 19321621
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional downregulation of ORF50/Rta by methotrexate inhibits the switch of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 from latency to lytic replication.
Curreli F; Cerimele F; Muralidhar S; Rosenthal LJ; Cesarman E; Friedman-Kien AE; Flore O
J Virol; 2002 May; 76(10):5208-19. PubMed ID: 11967335
[TBL] [Abstract][Full Text] [Related]
16. Caspase-Mediated Cleavage of the Transcription Factor Sp3: Possible Relevance to Cancer and the Lytic Cycle of Kaposi's Sarcoma-Associated Herpesvirus.
Chen LY; Chen LW; Hung CH; Lin CL; Wang SS; Chang PJ
Microbiol Spectr; 2022 Feb; 10(1):e0146421. PubMed ID: 35019687
[TBL] [Abstract][Full Text] [Related]
17. Modulation of global SUMOylation by Kaposi's sarcoma-associated herpesvirus and its effects on viral gene expression.
Wang J; Guo Y; Wang X; Zhao R; Wang Y
J Med Virol; 2017 Nov; 89(11):2011-2019. PubMed ID: 28639696
[TBL] [Abstract][Full Text] [Related]
18. X-box binding protein 1 contributes to induction of the Kaposi's sarcoma-associated herpesvirus lytic cycle under hypoxic conditions.
Dalton-Griffin L; Wilson SJ; Kellam P
J Virol; 2009 Jul; 83(14):7202-9. PubMed ID: 19403667
[TBL] [Abstract][Full Text] [Related]
19. Kruppel-associated box domain-associated protein-1 as a latency regulator for Kaposi's sarcoma-associated herpesvirus and its modulation by the viral protein kinase.
Chang PC; Fitzgerald LD; Van Geelen A; Izumiya Y; Ellison TJ; Wang DH; Ann DK; Luciw PA; Kung HJ
Cancer Res; 2009 Jul; 69(14):5681-9. PubMed ID: 19584288
[TBL] [Abstract][Full Text] [Related]
20. Suppressing Kaposi's Sarcoma-Associated Herpesvirus Lytic Gene Expression and Replication by RNase P Ribozyme.
Liu Y; Chen YC; Yan B; Liu F
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
